Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.
Crocs Inc. faces a sharp decline in share prices amid rising tariffs and waning popularity of its signature 'ugly' footwear. What's next for the brand?
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
Former US President Donald Trump warns of a stock market collapse if he's not re-elected, as Apple shares surge and Asian markets react. What do analysts say?
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
Glencore's shares surge after the commodities titan reveals strategic plans to list on the London Stock Exchange, signalling confidence in UK markets.
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
Drinks giant Diageo sees £18bn wiped off its market value as Latin American sales decline triggers investor alarm, with shares dropping to a three-year low.
Shadow Chancellor Rachel Reeves hints at potential tax increases on shares and dividends to fund public services, sparking debate among investors and policymakers.
Diageo's stock takes a hit after issuing a profit warning, dragging the FTSE 100 down. Analysts weigh in on the beverage giant's challenges in Latin America and beyond.
Shares in UK car finance lenders surged following a landmark Supreme Court decision that clears uncertainty around loan practices. Discover how this impacts consumers and the market.
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Former US President Donald Trump calls on British pharmaceutical companies to reduce drug prices for the NHS, sparking debate on healthcare affordability.
Melrose Industries sees a sharp rise in shares after upgrading its profit outlook, driven by strong aerospace performance.
New US tariffs could drastically increase the cost of essential medicines in Australia, putting the Pharmaceutical Benefits Scheme at risk. Experts warn of dire consequences for patients.
Biotech leader Moderna announces major layoffs, axing 150 jobs as part of a strategic cost-reduction plan. What does this mean for the future of mRNA vaccines?
Unilever faces a stock decline as popular brands Marmite and Magnum struggle in the Indian market, impacting investor confidence.
British American Tobacco (BAT) shares dropped sharply after the Biden administration announced plans to ban menthol cigarettes in the US, sparking investor concerns over future revenues.
Rolls-Royce reports a surge in profits driven by booming demand for its jet engines, sparking a sharp rise in share prices and investor optimism.
Airbus shares surged in London trading amid Boeing's ongoing challenges, signalling a potential shift in the aviation sector's balance of power.
Former US President Donald Trump's financial dealings in Asia come under the spotlight as China reportedly reviews his stake in a Bangkok-based company, raising geopolitical eyebrows.
AstraZeneca's CEO highlights the critical role of the US market amid looming Trump tariffs, emphasising the need for stable trade policies to sustain pharmaceutical innovation.
Novo Nordisk's blockbuster weight-loss drug Wegovy drives record sales, boosting shares and intensifying competition with Eli Lilly.
Games Workshop, the Nottingham-based creator of Warhammer, sees shares surge after announcing a significant rise in profits and sales, driven by global demand for its fantasy miniatures.
Pharmaceutical giant AstraZeneca faces a sharp decline in share prices following an unfavourable US court ruling, sparking investor concerns.
The FTSE 100 surged as investors reacted to positive economic signals. Discover which stocks led the gains and what this means for your portfolio.
Sportswear giant Puma faces a sharp decline in shares as US tariffs on Chinese goods disrupt its athleisure market dominance.